Connection

Vijay Gayam to Antiviral Agents

Back to Details
This is a "connection" page, showing publications Vijay Gayam has written about Antiviral Agents.
Vijay Gayam
Connection Strength
0.337
Antiviral Agents
  1. Outcomes of Direct-Acting Antiviral Treatment of Psychiatric Patients with Comorbid Hepatitis C Virus Infection. Dig Dis. 2020; 38(3):232-239.
    View in: PubMed
    Score: 0.078
  2. Real-world study of hepatitis C treatment with direct-acting antivirals in patients with drug abuse and opioid agonist therapy. Scand J Gastroenterol. 2019 May; 54(5):646-655.
    View in: PubMed
    Score: 0.076
  3. Real-World Clinical Efficacy and Tolerability of Direct-Acting Antivirals in Hepatitis C Monoinfection Compared to Hepatitis C/Human Immunodeficiency Virus Coinfection in a Community Care Setting. Gut Liver. 2018 11 15; 12(6):694-703.
    View in: PubMed
    Score: 0.073
  4. Sofosbuvir based regimens in the treatment of chronic hepatitis C genotype 1 infection in African-American patients: a community-based retrospective cohort study. Eur J Gastroenterol Hepatol. 2018 10; 30(10):1200-1207.
    View in: PubMed
    Score: 0.073
  5. Presenting characteristics, comorbidities, and outcomes of patients coinfected with COVID-19 and Mycoplasma pneumoniae in the USA. J Med Virol. 2020 10; 92(10):2181-2187.
    View in: PubMed
    Score: 0.020
  6. Clinical efficacy and tolerability of direct-acting antivirals in elderly patients with chronic hepatitis C. Eur J Gastroenterol Hepatol. 2017 Jul; 29(7):767-776.
    View in: PubMed
    Score: 0.017
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.